Mon, Mar 2, 2015, 7:59 AM EST - U.S. Markets open in 1 hr 31 mins

Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • macrocosmonaut macrocosmonaut Dec 10, 2012 10:39 AM Flag

    CLDX - are the study results correct?

    Even if the new trial results are interesting - we are talking about around 122 patients in this 2b study - and it seems to be that this study isn´t double blinded.

    In all patients there is no significant benefit to the treated patient population. Only a subgroup shows some effets - but numbers are to low in order to determine a significant statistic significance.

    So the article is falsifying when he write a p=0.008 as significant effect in 122 patient 2b study. A serious statistic needs minimum 900-1000 patients in order to determine any statistic significance.

    Such an interpretation is missleading and is questionable to show such results in bigger and mor expensive double blinded multiyear phase III trial.

    M.

    Sentiment: Sell

 
CLDX
25.54+0.60(+2.41%)Feb 27 3:59 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.